Intervac Entrovac

COMPOSITION: EACH DOSE (1 ML) CONTAINS TOXOIDS OF CLOSTRIDIUM PERFRINGENS TYPE B :鈥斺�斺�斺�斺�斺��250 HU TOXOIDS OF CLOSTRIDIUM PERFRINGENS TYPE D: 鈥斺�斺�斺��250 HU RECOMMENDED CLINICAL USE: ENTEROTOXAEMIA VACCINE IS THE FORMALIZED TOXIN鈥楽 SUSPENSION OF LOCALLY ISOLATED ANAEROBIC BACTERIA CLOSTRIDIUM PERFRINGENS TYPE B & D WHICH PARENTAL DEMONSTRATION PRODUCES HIGH GRADE IMMUNITY IN SHEEP & GOATS, DURING FIELD OUTBREAK CHALLENGE OF THE MENTIONED ORGANISM. PROPERTIES: SINCE THIS VACCINE IS FORMULATED WITH PURIFIED TOXINS AND CELLULAR ANTIGENS, DULY INACTIVATED AND ADJUVANTED, IT CAN INDUCE HIGH LEVELS OF SPECIFIC ANTIBODIES AS WELL AS ELEVATED VALUES OF ANTITOXINS IN THE VACCINATED ANIMALS. THEREFORE, LNTERVAC ENTEROVAC VACCINE IS AN ADEQUATE PRODUCT FOR CONTROLLING DIFFERENT TYPES OF CLOSTRIDIOSIS THAT AFFECT ANIMALS UNDER CERTAIN CIRCUMSTANCES, SUCH AS SUDDEN CHANGES IN THE DIET, EXCESS OF ENERGY IN FEEDSTUFF, PROLONGED TREATMENTS WITH ANTIBIOTICS, ETC., WHICH PROVOKE AN ABRUPT ALTERATION IN THE NORMAL INTESTINAL FLORA OF RUMINANTS. Each dose (1ml) contains Active Toxoid of Clostridium perfringens type B: --250 HU Toxoid of Clostridium perfringens Type D: --250 HU